ResMed is a producer and international distributor offering a huge selection of modern CPAP devices and masks for the treatment of obstructive sleep apnea. In its production, it uses the latest available technologies, all in order to create devices that will provide sleep comfort to millions of patients around the world, reducing the negative effects of OSA diseases and thus reducing the costs of health care.
The rich ResMed offer includes:
CPAP devices for continuous pressure in the airways,
anatomical AirFit mask perfectly matching the shape of the face.
For more information, please visit our website www.zdrowysen.info.
AirFit 30 masks
CPAP cameras
47.74.Z - Retail sale of medical and orthopedic products
26.11.Z - Manufacture of electronic components
26.60.Z - Manufacture of irradiation equipment, electromedical and electrotherapeutic equipment
32.50.Z - Production of medical devices, instruments, and products, including dental products
33.14.Z - Repair and maintenance of electrical devices
46.46.Z - Wholesale trade of pharmaceutical and medical products
62.03.Z - Activities related to programming, IT consulting, and related activities
63.99.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
86.90.C - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,2 | 1,4 | 2,5 | 80,9 |
EBITDA | 2,3 | 3 | 3,2 | 7,2 |
Short time liabilities | 2,3 | 4,5 | 8,4 | 85,5 |
Equity capital | 7,8 | 8,8 | 10,7 | 22,2 |
Operating profit (EBIT) | 1,5 | 2,3 | 2,2 | -6,2 |
Assets | 12,4 | 15,9 | 23,1 | 45,6 |
Net profit (loss) | 1,1 | 1 | 1,9 | 93,5 |
Cash | 1,9 | 1,9 | 0,8 | -57,9 |
Net income from sale | 29,5 | 38,4 | 41,2 | 7,2 |
Liabilities and provisions for liabilities | 4,7 | 7,1 | 12,4 | 74,5 |
Working assets | 11,4 | 14,7 | 18,6 | 26,8 |
Depreciation | 0,7 | 0,7 | 1,1 | 49,5 |
% | % | % | p.p. | |
Profitability of capital | 13,9 | 11,5 | 18,2 | 6,7 |
Equity capital to total assets | 62,5 | 55,2 | 46,3 | -8,9 |
Gross profit margin | 4 | 3,7 | 6,2 | 2,5 |
EBITDA Margin | 7,7 | 7,9 | 7,9 | 0 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 28 | 43 | 74 | 31 |
Current financial liquidity indicator | 4.368300914764404 | 3.0132839679718018 | 1.9977120161056519 | -1 |
Net dept to EBITDA | -0.8493059873580933 | -0.6355929970741272 | -0.24961982667446136 | 0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane